Palvella Therapeutics logo

Palvella Therapeutics Share Price Today

(NASDAQ: PVLA)

Palvella Therapeutics share price is $21.67 & ₹1,884.62 as on 6 Mar 2025, 2.30 'hrs' IST

$21.67

0.97

(4.69%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Palvella Therapeutics share price in Dollar and Rupees. Guide to invest in Palvella Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Palvella Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Palvella Therapeutics share price movements

  • Today's Low: $20.70
    Today's High: $23.59

    Day's Volatility :12.25%

  • 52 Weeks Low: $11.17
    52 Weeks High: $21.71

    52 Weeks Volatility :48.55%

Palvella Therapeutics (PVLA) Returns

PeriodPalvella Therapeutics, Inc.Index (Russel 2000)
3 Months
26.53%
0.0%
6 Months
20.0%
0.0%
1 Year
53.02%
0.0%
3 Years
-91.17%
-11.6%

Palvella Therapeutics (PVLA) Key Statistics

in dollars & INR

Previous Close
$20.7
Open
$20.835
Today's High
$23.59
Today's Low
$20.7
Market Capitalization
$219.4M
Today's Volume
$8.0K
52 Week High
$23.59
52 Week Low
$11.17
Revenue TTM
$0.0
Earnings Per Share (EPS)
$1.97
PE Ratio
9.92
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Palvella Therapeutics Stock (PVLA) from India?

It is very easy for Indian residents to invest directly in Palvella Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Palvella Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Palvella Therapeutics or PVLA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Palvella Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Palvella Therapeutics shares which would translate to 0.040 fractional shares of Palvella Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Palvella Therapeutics, in just a few clicks!

Returns in Palvella Therapeutics (PVLA) for Indian investors in Rupees

The Palvella Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Palvella Therapeutics investment value today

Current value as on today

₹1,65,125

Returns

₹65,125

(+65.13%)

Returns from Palvella Therapeutics Stock

₹60,163 (+60.16%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Palvella Therapeutics (PVLA)

90%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Palvella Therapeutics Stock from India on INDmoney has increased by 90% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Palvella Therapeutics

Analyst Forecast on Palvella Therapeutics Stock (PVLA)

What analysts predicted

Upside of 72.28%

Target:

$37.33

Current:

$21.67

Insights on Palvella Therapeutics Stock (Ticker Symbol: PVLA)

  • Price Movement

    In the last 7 days, PVLA stock has moved up by 10.1%
  • PVLA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 11.9%
  • PVLA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 138.9%

Palvella Therapeutics Technicals Summary

Sell

Neutral

Buy

Palvella Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Palvella Therapeutics (PVLA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Palvella Therapeutics, Inc. logo
49.03%
20.0%
53.02%
-91.17%
-89.97%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Palvella Therapeutics, Inc. logo
9.92
9.92
NA
-3.27
0.0
0.0
NA
-15.28
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Palvella Therapeutics, Inc. logo
NA
$219.4M
-89.97%
9.92
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Palvella Therapeutics

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.
Organization
Palvella Therapeutics
Employees
0
CEO
Mr. Wesley H. Kaupinen
Industry
Miscellaneous

Management People of Palvella Therapeutics

NameTitle
Mr. Wesley H. Kaupinen
Founder, President, CEO & Director
Mr. Matthew E. Korenberg
CFO & Treasurer
Ms. Kathleen Goin
Chief Operating Officer
Dr. Braham Shroot Ph.D.
Chief Technical Officer
Dr. Jeffrey Martini Ph.D.
Chief Scientific Officer
Ms. Bohan Wei
Vice President of Corporate Development & New Product Planning
Ms. Emily Cook
Senior Vice President of Clinical Operations

Important FAQs about investing in PVLA Stock from India :

What is Palvella Therapeutics share price today?

Palvella Therapeutics share price today stands at $21.67, Open: $20.84 ; Previous Close: $20.70 ; High: $23.59 ; Low: $20.70 ; 52 Week High: $21.71 ; 52 Week Low: $11.17.

The stock opens at $20.84, after a previous close of $20.70. The stock reached a daily high of $23.59 and a low of $20.70, with a 52-week high of $21.71 and a 52-week low of $11.17.

Can Indians buy Palvella Therapeutics shares?

Yes, Indians can invest in the Palvella Therapeutics (PVLA) from India.

With INDmoney, you can buy Palvella Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Palvella Therapeutics at zero transaction cost.

How can I buy Palvella Therapeutics shares from India?

It is very easy to buy Palvella Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Palvella Therapeutics (PVLA) be purchased?

Yes, you can buy fractional shares of Palvella Therapeutics with INDmoney app.

What are the documents required to start investing in Palvella Therapeutics stocks?

To start investing in Palvella Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Palvella Therapeutics Stock (PVLA)?

Today’s highest price of Palvella Therapeutics (PVLA) is $23.59.

Today’s lowest price of Palvella Therapeutics (PVLA) is $20.70.

What is today's market capitalisation of Palvella Therapeutics?

Today's market capitalisation of Palvella Therapeutics PVLA is 219.4M

What is the 52 Week High and Low Range of Palvella Therapeutics Stock (PVLA)?

  • 52 Week High

    $21.71

  • 52 Week Low

    $11.17

What are the historical returns of Palvella Therapeutics (PVLA)?

  • 1 Month Returns

    49.03%

  • 3 Months Returns

    20%

  • 1 Year Returns

    53.02%

  • 5 Years Returns

    -89.97%

Who is the Chief Executive Officer (CEO) of Palvella Therapeutics ?

Mr. Wesley H. Kaupinen is the current Chief Executive Officer (CEO) of Palvella Therapeutics.